These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1083 related items for PubMed ID: 18223285

  • 21. Advantages and limits of ADAMTS13 testing in the prognostic assessment of thrombotic thrombocytopenic purpura.
    Mannucci PM, Franchini M.
    Presse Med; 2012 Mar; 41(3 Pt 2):e157-62. PubMed ID: 22244722
    [Abstract] [Full Text] [Related]

  • 22. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features.
    Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN.
    Pediatr Blood Cancer; 2013 Oct; 60(10):1676-82. PubMed ID: 23729372
    [Abstract] [Full Text] [Related]

  • 23. ADAMTS13 related markers and von Willebrand factor in plasma from patients with thrombotic microangiopathy (TMA).
    Kobayashi T, Wada H, Nishioka N, Yamamoto M, Matsumoto T, Tamaru T, Nomura S, Masuya M, Mori Y, Nakatani K, Nishikawa M, Katayama N, Nobori T.
    Thromb Res; 2008 Oct; 121(6):849-54. PubMed ID: 17900666
    [Abstract] [Full Text] [Related]

  • 24. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
    Tersteeg C, Verhenne S, Roose E, Schelpe AS, Deckmyn H, De Meyer SF, Vanhoorelbeke K.
    Expert Rev Hematol; 2016 Oct; 9(2):209-21. PubMed ID: 26581428
    [Abstract] [Full Text] [Related]

  • 25. von Willebrand factor propeptide to antigen ratio in acquired thrombotic thrombocytopenic purpura.
    Stufano F, LA Marca S, Pontiggia S, Musallam KM, Peyvandi F.
    J Thromb Haemost; 2012 Apr; 10(4):728-30. PubMed ID: 22268915
    [No Abstract] [Full Text] [Related]

  • 26. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
    Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P, Poullin P, de Maistre E, Provôt F, Delmas Y, Perez P, Benhamou Y, Stepanian A, Coppo P, Veyradier A, French Reference Center for Thrombotic Microangiopathies.
    Lancet Haematol; 2016 May; 3(5):e237-45. PubMed ID: 27132698
    [Abstract] [Full Text] [Related]

  • 27. ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment.
    Rurali E, Banterla F, Donadelli R, Bresin E, Galbusera M, Gastoldi S, Peyvandi F, Underwood M, Remuzzi G, Noris M.
    Clin J Am Soc Nephrol; 2015 Nov 06; 10(11):2002-12. PubMed ID: 26342041
    [Abstract] [Full Text] [Related]

  • 28. Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura.
    Cataland SR, Jin M, Lin S, Kraut EH, George JN, Wu HM.
    Am J Hematol; 2008 Dec 06; 83(12):911-5. PubMed ID: 18821711
    [Abstract] [Full Text] [Related]

  • 29. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Sadler JE.
    Blood; 2008 Jul 01; 112(1):11-8. PubMed ID: 18574040
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.
    Zheng XL.
    Annu Rev Med; 2015 Jul 01; 66():211-25. PubMed ID: 25587650
    [Abstract] [Full Text] [Related]

  • 32. Thrombotic thrombocytopenic purpura: a moving target.
    Sadler JE.
    Hematology Am Soc Hematol Educ Program; 2006 Jul 01; ():415-20. PubMed ID: 17124092
    [Abstract] [Full Text] [Related]

  • 33. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura.
    Froehlich-Zahnd R, George JN, Vesely SK, Terrell DR, Aboulfatova K, Dong JF, Luken BM, Voorberg J, Budde U, Sulzer I, Lämmle B, Kremer Hovinga JA.
    Haematologica; 2012 Feb 01; 97(2):297-303. PubMed ID: 21993669
    [Abstract] [Full Text] [Related]

  • 34. A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.
    Nikolaou M, Karakantza M, Adonakis G, Theodorou G, Zoumbos N, Decavalas G.
    Med Pregl; 2012 Feb 01; 65(9-10):436-9. PubMed ID: 23214340
    [Abstract] [Full Text] [Related]

  • 35. Survival and relapse in patients with thrombotic thrombocytopenic purpura.
    Kremer Hovinga JA, Vesely SK, Terrell DR, Lämmle B, George JN.
    Blood; 2010 Feb 25; 115(8):1500-11; quiz 1662. PubMed ID: 20032506
    [Abstract] [Full Text] [Related]

  • 36. The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura.
    Luken BM, Turenhout EA, Hulstein JJ, Van Mourik JA, Fijnheer R, Voorberg J.
    Thromb Haemost; 2005 Feb 25; 93(2):267-74. PubMed ID: 15711742
    [Abstract] [Full Text] [Related]

  • 37. The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura.
    O'Brien KL, Price TH, Howell C, Delaney M.
    J Clin Apher; 2013 Dec 25; 28(6):416-21. PubMed ID: 23857424
    [Abstract] [Full Text] [Related]

  • 38. Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura.
    Mazepa MA, Raval JS, Moll S, Ma A, Park YA.
    Br J Haematol; 2014 Mar 25; 164(6):900-2. PubMed ID: 24345005
    [No Abstract] [Full Text] [Related]

  • 39. Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma.
    Isonishi A, Bennett CL, Plaimauer B, Scheiflinger F, Matsumoto M, Fujimura Y.
    Transfusion; 2015 Oct 25; 55(10):2321-30. PubMed ID: 26058519
    [Abstract] [Full Text] [Related]

  • 40. Current management of thrombotic thrombocytopenic purpura.
    Kremer Hovinga JA, Meyer SC.
    Curr Opin Hematol; 2008 Sep 25; 15(5):445-50. PubMed ID: 18695366
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.